AmitEtkinMD

Associate Professor, Psychiatry & Behavioral Science, Stanford University Faculty, Stanford Neurosciences Institute, Stanford University Investigator, MIRECC, Palo Alto VA

Join to view full profile

Dr. Etkin is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Etkin's full profile

Already have an account?

Office
401 Quarry Rd
Stanford, CA 94304
Phone+1 650-723-6661

Education & Training

Stanford Health Care-Sponsored Stanford UniversityResidency, Psychiatry, 2006 - 2010
Columbia University Vagelos College of Physicians and SurgeonsClass of 2006

Certifications & Licensure

CA State Medical License 2007 - 2025
American Board of Psychiatry and Neurology Psychiatry

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011

Clinical Trials

Neurobehavioral Intervention as a Novel Treatment Approach for Emotion-Regulatory Deficits Start of enrollment: 2011 Jan 01
Completed
Not Applicable
Brain Imaging of Psychotherapy for Posttraumatic Stress Disorder (PTSD) Start of enrollment: 2010 Sep 01
Completed
Not Applicable
A Novel Neurobehavioral Intervention for Emotion Regulation in Anxiety and Depression Across the Lifespan Start of enrollment: 2014 Feb 01
Completed
Not Applicable
Computerized Interventions for College Students' Cognitive Functioning and Mental Well-being Start of enrollment: 2012 Sep 01
Completed
Not Applicable
Use of a Novel Neuroplasticity-based Neurobehavioral Intervention for PTSD Start of enrollment: 2012 Sep 01
Completed
Not Applicable
Brain Imaging of rTMS Treatment for Depression Start of enrollment: 2012 Sep 01
Completed
Not Applicable
Brain-Based Biomarkers in Response to TMS in MDD Start of enrollment: 2016 Mar 01
Completed
Biomarker Establishment for Superior Treatment of PTSD Start of enrollment: 2016 Sep 01
Completed
Join now to see all

Publications & Presentations

PubMed

Towards a consensus roadmap for a new diagnostic framework for mental disorders.
Martien J H Kas, Steven Hyman, Leanne M Williams, Diego Hidalgo-Mazzei, Quentin J M Huys
European Neuropsychopharmacology. 2025-01-01
Neuroimaging-based variability in subtyping biomarkers for psychiatric heterogeneity.
Zhenfu Wen, Mira Z Hammoud, Carole E Siegel, Eugene M Laska, Duna Abu-Amara
Molecular Psychiatry. 2024-11-07
3 citations
Opportunities for use of neuroimaging in de-risking drug development and improving clinical outcomes in psychiatry: an industry perspective.
Amit Etkin, Jessica Powell, Adam J Savitz
Neuropsychopharmacology. 2024-11-01

Journal Articles

Effect of Repetitive Transcranial Magnetic Stimulation on Treatment-Resistant Major Depression in US Veterans
Jerome A Yesavage, Michael Thase, Steven D Forman, Amit Etkin, Mark S George, JAMA

Authored Content

Decoding MoodOctober 2018
Decoding MoodOctober 2018
S132. Cerebral Blood Perfusion Predictors of Antidepressant Response in Major Depressive DisorderApril 2018
S131. Resting State Functional Connectivity Patterns Differentially Predict Treatment Outcomes to Sertraline Versus Placebo in Patients with Major Depressive DisorderApril 2018
Join now to see all

Press Mentions

Alto Neuroscience Announces Data Presented at the 63rd Annual Meeting of the American College of NeuropsychopharmacologyDecember 11th, 2024
Spravato Is Just the Beginning in a New Wave of Depression MedsNovember 11th, 2024
Precision Psychiatry and the Mental Health Treatment RevolutionOctober 8th, 2024
Join now to see all